nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.159	0.612	CbGbCtD
Bisoprolol—Serum triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.111	0.151	CcSEcCtD
Bisoprolol—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.101	0.389	CbGbCtD
Bisoprolol—Toxicity to various agents—Cyclosporine—focal segmental glomerulosclerosis	0.0281	0.038	CcSEcCtD
Bisoprolol—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.022	0.0298	CcSEcCtD
Bisoprolol—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.022	0.0298	CcSEcCtD
Bisoprolol—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0171	0.0232	CcSEcCtD
Bisoprolol—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.0138	0.0187	CcSEcCtD
Bisoprolol—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.0138	0.0187	CcSEcCtD
Bisoprolol—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0173	CcSEcCtD
Bisoprolol—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0169	CcSEcCtD
Bisoprolol—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0166	CcSEcCtD
Bisoprolol—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.0162	CcSEcCtD
Bisoprolol—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0138	CcSEcCtD
Bisoprolol—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00999	0.0135	CcSEcCtD
Bisoprolol—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.0092	0.0124	CcSEcCtD
Bisoprolol—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00889	0.012	CcSEcCtD
Bisoprolol—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00883	0.0119	CcSEcCtD
Bisoprolol—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.0086	0.0116	CcSEcCtD
Bisoprolol—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00844	0.0114	CcSEcCtD
Bisoprolol—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00775	0.0105	CcSEcCtD
Bisoprolol—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00762	0.0103	CcSEcCtD
Bisoprolol—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00734	0.00992	CcSEcCtD
Bisoprolol—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00726	0.00982	CcSEcCtD
Bisoprolol—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.007	0.00947	CcSEcCtD
Bisoprolol—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00664	0.00898	CcSEcCtD
Bisoprolol—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.00881	CcSEcCtD
Bisoprolol—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.00881	CcSEcCtD
Bisoprolol—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00649	0.00877	CcSEcCtD
Bisoprolol—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00646	0.00873	CcSEcCtD
Bisoprolol—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00634	0.00858	CcSEcCtD
Bisoprolol—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00629	0.0085	CcSEcCtD
Bisoprolol—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00623	0.00843	CcSEcCtD
Bisoprolol—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00618	0.00835	CcSEcCtD
Bisoprolol—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00615	0.00832	CcSEcCtD
Bisoprolol—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.00818	CcSEcCtD
Bisoprolol—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00597	0.00808	CcSEcCtD
Bisoprolol—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00597	0.00808	CcSEcCtD
Bisoprolol—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00583	0.00788	CcSEcCtD
Bisoprolol—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00578	0.00782	CcSEcCtD
Bisoprolol—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00574	0.00776	CcSEcCtD
Bisoprolol—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00552	0.00747	CcSEcCtD
Bisoprolol—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00532	0.0072	CcSEcCtD
Bisoprolol—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00527	0.00712	CcSEcCtD
Bisoprolol—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.0071	CcSEcCtD
Bisoprolol—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.00698	CcSEcCtD
Bisoprolol—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.00695	CcSEcCtD
Bisoprolol—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00496	0.0067	CcSEcCtD
Bisoprolol—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00491	0.00664	CcSEcCtD
Bisoprolol—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00485	0.00655	CcSEcCtD
Bisoprolol—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00459	0.0062	CcSEcCtD
Bisoprolol—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.00611	CcSEcCtD
Bisoprolol—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00448	0.00606	CcSEcCtD
Bisoprolol—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00443	0.00599	CcSEcCtD
Bisoprolol—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.00596	CcSEcCtD
Bisoprolol—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.00591	CcSEcCtD
Bisoprolol—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.00591	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00425	0.00575	CcSEcCtD
Bisoprolol—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.0057	CcSEcCtD
Bisoprolol—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.00547	CcSEcCtD
Bisoprolol—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.00545	CcSEcCtD
Bisoprolol—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00401	0.00543	CcSEcCtD
Bisoprolol—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.004	0.00541	CcSEcCtD
Bisoprolol—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.00536	CcSEcCtD
Bisoprolol—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00389	0.00526	CcSEcCtD
Bisoprolol—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00376	0.00508	CcSEcCtD
Bisoprolol—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.00506	CcSEcCtD
Bisoprolol—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.00495	CcSEcCtD
Bisoprolol—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00492	CcSEcCtD
Bisoprolol—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.0036	0.00487	CcSEcCtD
Bisoprolol—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00482	CcSEcCtD
Bisoprolol—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00478	CcSEcCtD
Bisoprolol—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.00465	CcSEcCtD
Bisoprolol—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00456	CcSEcCtD
Bisoprolol—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.00445	CcSEcCtD
Bisoprolol—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00326	0.0044	CcSEcCtD
Bisoprolol—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00436	CcSEcCtD
Bisoprolol—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00321	0.00434	CcSEcCtD
Bisoprolol—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.00428	CcSEcCtD
Bisoprolol—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00427	CcSEcCtD
Bisoprolol—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00414	CcSEcCtD
Bisoprolol—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00404	CcSEcCtD
Bisoprolol—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00404	CcSEcCtD
Bisoprolol—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00404	CcSEcCtD
Bisoprolol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.00403	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00401	CcSEcCtD
Bisoprolol—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00399	CcSEcCtD
Bisoprolol—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00395	CcSEcCtD
Bisoprolol—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00391	CcSEcCtD
Bisoprolol—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00387	CcSEcCtD
Bisoprolol—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00385	CcSEcCtD
Bisoprolol—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.0038	CcSEcCtD
Bisoprolol—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00379	CcSEcCtD
Bisoprolol—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00376	CcSEcCtD
Bisoprolol—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00375	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00353	CcSEcCtD
Bisoprolol—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.0035	CcSEcCtD
Bisoprolol—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00348	CcSEcCtD
Bisoprolol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00345	CcSEcCtD
Bisoprolol—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00344	CcSEcCtD
Bisoprolol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00341	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00335	CcSEcCtD
Bisoprolol—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00334	CcSEcCtD
Bisoprolol—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00331	CcSEcCtD
Bisoprolol—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00331	CcSEcCtD
Bisoprolol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00319	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.00317	CcSEcCtD
Bisoprolol—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00308	CcSEcCtD
Bisoprolol—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00306	CcSEcCtD
Bisoprolol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00306	CcSEcCtD
Bisoprolol—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00285	CcSEcCtD
Bisoprolol—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00278	CcSEcCtD
Bisoprolol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00274	CcSEcCtD
Bisoprolol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00265	CcSEcCtD
Bisoprolol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00256	CcSEcCtD
Bisoprolol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00246	CcSEcCtD
Bisoprolol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00244	CcSEcCtD
Bisoprolol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00244	CcSEcCtD
Bisoprolol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00243	CcSEcCtD
Bisoprolol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.0023	CcSEcCtD
